Sea Crest Wealth Management, LLC Moderna, Inc. Transaction History
Sea Crest Wealth Management, LLC
- $902 Million
- Q3 2024
A detailed history of Sea Crest Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Sea Crest Wealth Management, LLC holds 5,991 shares of MRNA stock, worth $238,262. This represents 0.04% of its overall portfolio holdings.
Number of Shares
5,991
Previous 6,624
9.56%
Holding current value
$238,262
Previous $786,000
49.11%
% of portfolio
0.04%
Previous 0.09%
Shares
21 transactions
Others Institutions Holding MRNA
# of Institutions
954Shares Held
241MCall Options Held
9.93MPut Options Held
17.6M-
Baillie Gifford & CO42.5MShares$1.69 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.6 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.02 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$670 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$287 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...